Weekly Recap | Bristol Myers Squibb -0.91%, consensus target above spotWeekly Review·Sep 19 at 05:46 AMBMY+0.51%
Weekly Recap | Bristol Myers Squibb -4.76%, positive CAR-T data but studies pausedWeekly Review·Sep 12 at 07:50 AMBMY+0.51%
Weekly Recap | Bristol Myers Squibb +0.36%, CAR-T trial pauses in focusWeekly Review·Sep 5 at 06:16 AMBMY+0.51%
